MedTrace Logo

Tocotrienols for School-going Children With ADHD

NCT01855984 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2013-06-14

No results posted yet for this study

Summary

The purpose of this study is to determine if tocotrienol supplementation given to school going children with ADHD will result in reduction of their ADHD symptoms.

Conditions

  • Attention Deficit Disorder With Hyperactivity

Interventions

DIETARY_SUPPLEMENT

Oral mixed tocotrienols

200mg per day

DIETARY_SUPPLEMENT

Placebo

Capsules containing soya bean oil that has similar appearance with the mixed tocotrienol capsules

Sponsors & Collaborators

  • Penang Hospital, Malaysia

    collaborator OTHER_GOV

  • RCSI & UCD Malaysia Campus

    lead OTHER

Principal Investigators

  • May Loong Tan, MRCPCH(UK) · RCSI & UCD Malaysia Campus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01855984 on ClinicalTrials.gov